Jamie Y Hur
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jamie Y Hur as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:03 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05509582 · Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated CytopeniasNational Heart, Lung, and Blood Institute (NHLBI) · withdrawn · Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD · principal investigator
- Ph2NCT05502783 · Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated CytopeniasNational Heart, Lung, and Blood Institute (NHLBI) · terminated · Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:03 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed
- Anterior transobturator polypropylene mesh in the correction of cystocele: 2-point method vs 4-point method.J Minim Invasive Gynecol · 20124 citationsRCR 0.2